News

Public · Published

Virtuix Expects to Report Strong Second Quarter Revenue Growth Following Meta Quest Launch; Schedules Q2 FY2027 Earnings Call

Virtuix said it expects strong second quarter fiscal year 2027 revenue growth, partly from higher Omni One sales after its June launch of Omni One for Quest with Meta. The company called these expectations preliminary and scheduled an earnings call for November 16, 2026.

Published:

Updated:

What happened

Virtuix said it expects strong second quarter fiscal year 2027 revenue growth, partly from higher Omni One sales after its June launch of Omni One for Quest with Meta. The company called these expectations preliminary and scheduled an earnings call for November 16, 2026.

Confirmed

Global impact / market context

Higher Omni One sales would lift revenue, but the company says the numbers are preliminary, so final results could differ. Investors will compare actual revenue and profit per sale with this outlook, and the earnings call may clarify how much the Meta Quest launch contributed.

Analyst inference

Virtuix sells full-body simulation systems for entertainment, defense, and healthcare, and reports recent sales to the U.S. Army, Navy, and Department of Veterans Affairs. That mix means revenue depends on consumer demand for Omni One plus government and enterprise orders, which can be uneven.

Analyst inference

What to watch

  1. Virtuix will host its second quarter fiscal year 2027 conference call on Monday, November 16, 2026, at 8:30 a.m. Eastern Time, with CEO Jan Goetgeluk and CFO Thomas McGinnis presenting results. Confirmed
  2. The call will cover the defense and enterprise footprint, recent sales to the U.S. Army, U.S. Navy, and U.S. Department of Veterans Affairs, humanoid robotics developments, and the upcoming autism therapy pilot. Confirmed
  3. Watch how much reported revenue growth comes from the Meta Quest launch versus defense and enterprise orders, and whether final quarter-end closing procedures change the preliminary outlook. Analyst inference

Evidence